Arrhythmia Burden and Heart Rate Response During Exercise in Anderson-Fabry Disease
- PMID: 36069908
- PMCID: PMC9632385
- DOI: 10.14503/THIJ-20-7363
Arrhythmia Burden and Heart Rate Response During Exercise in Anderson-Fabry Disease
Abstract
Patients with Anderson-Fabry disease (AFD) have an elevated incidence of resting arrhythmias and ischemic heart disease, but their exercise arrhythmia burden and ischemic changes are not well understood. In addition, little research has been done on heart rate recovery in these patients. We retrospectively reviewed charts of patients with AFD who underwent maximal effort cardiopulmonary exercise testing (CPET) (n=44; 38.2 ± 13.8 yr; 23 men) from 2012 through 2018. Electrocardiographic, Holter monitoring, echocardiographic, cardiac magnetic resonance imaging, and patient demographic data were collected. No patient had adverse events that necessitated CPET termination, whereas 25 (57%) had ectopy during CPET, including 3 (7%) with frequent premature atrial contractions and 5 (11%) with frequent premature ventricular contractions. The ectopic burden was higher during resting electrocardiographic monitoring before exercise. In addition, 7 patients (16%) had pathologic ST-segment or T-wave changes on CPET, defined as ST-segment changes ≥2 mm. Among the patients who had concurrent cardiac magnetic resonance findings with their CPET (n=27), ST-segment or T-wave changes were associated with left ventricular myocardial mass (r=0.43, P=0.02). Chronotropic incompetence was seen during CPET in 28 patients (64%); however, only 2 patients (4%) had abnormal heart rate recovery at 1 minute. This study shows that patients with AFD can safely undergo exercise testing but have a high incidence of exercise-induced arrhythmias and ischemic changes. Ischemic electrocardiographic changes during exercise testing are associated with myocardial mass. Despite the chronotropic incompetence associated with AFD, heart rate recovery appears to be generally preserved in these patients.
Keywords: Anderson-Fabry disease/complications; Arrhythmia; cardiopulmonary exercise test; echocardiography; electrocardiography; exercise tolerance; heart rate recovery; heart rate response.
© 2022 by the Texas Heart® Institute, Houston.
Conflict of interest statement
Similar articles
-
Arrhythmia and Clinical Cardiac Findings in Children With Anderson-Fabry Disease.Am J Cardiol. 2017 Jul 15;120(2):251-255. doi: 10.1016/j.amjcard.2017.04.016. Epub 2017 Apr 27. Am J Cardiol. 2017. PMID: 28550929
-
The influence of water-based training on arrhythmia in patients with stable coronary artery disease and preserved left ventricular function.Cardiol J. 2016;23(1):93-9. doi: 10.5603/CJ.a2015.0065. Epub 2015 Sep 28. Cardiol J. 2016. PMID: 26412610
-
Heart rate dependency of premature ventricular contractions. Correlation between electrocardiographic monitoring and exercise-related patterns.Eur Heart J. 1997 Oct;18(10):1642-8. doi: 10.1093/oxfordjournals.eurheartj.a015145. Eur Heart J. 1997. PMID: 9347276
-
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.Heart Fail Rev. 2015 Mar;20(2):179-91. doi: 10.1007/s10741-014-9452-9. Heart Fail Rev. 2015. PMID: 25030479 Review.
-
Role of cardiac imaging in Anderson-Fabry cardiomyopathy.Cardiovasc Ultrasound. 2019 Jan 23;17(1):1. doi: 10.1186/s12947-019-0151-5. Cardiovasc Ultrasound. 2019. PMID: 30674321 Free PMC article. Review.
Cited by
-
Rate-Responsive Cardiac Pacing: Technological Solutions and Their Applications.Sensors (Basel). 2023 Jan 27;23(3):1427. doi: 10.3390/s23031427. Sensors (Basel). 2023. PMID: 36772467 Free PMC article. Review.
-
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations.Front Cardiovasc Med. 2024 Jan 24;11:1341590. doi: 10.3389/fcvm.2024.1341590. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38327490 Free PMC article. Review.
References
-
- Duro G, Musumeci MB, Colomba P, Zizzo C, Albeggiani G, Mastromarino V, et al. Novel α-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease. Gene . 2014;535(2):365–9. - PubMed
-
- Seydelmann N, Wanner C, Störk S, Ertl G, Weidemann F. Fabry disease and the heart. Best Pract Res Clin Endocrinol Metab . 2015;29(2):195–204. - PubMed
-
- Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D et al. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease. Clin Genet . 2004;66(2):158–65. - PubMed
-
- Waldek S. PR interval and the response to enzyme-replacement therapy for Fabry's disease. N Engl J Med . 2003;348(12):1186–7. - PubMed
-
- Eisenmann JC, Guseman EH, Morrison K, Tucker J, Smith L, Stratbucker W. Graded exercise testing in a pediatric weight management center: the DeVos protocol. Child Obes . 2015;11(6):657–63. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical